Physician

Edward James Lee, M.D.

According to 2025 Medicare claims, Edward Lee, M.D. (NPI: 1043285190) practices hematology/oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Howard, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY P.A. (NPI: 1396710703; TIN: 113652573) and primary practice location at 21044-3257.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,000 traditional Medicare patients, billed 253,481 HCPCS/CPT codes, and received $4,253,018 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 764 prescription claims across 146 beneficiaries totaling $4,619,072 in drug costs, led by Pomalyst (Pomalidomide). 2022 DME data shows 41 claims. Open Payments data shows 36 records totaling $1,622. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,805,338 to $4,253,018. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $945,186 to $4,619,072. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.3M2015 Medicare payment: $1,805,338 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,763,149 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,076,294 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,069,267 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,624,703 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,182,508 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,637,922 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,332,755 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,078,315 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,253,018 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015609153,632$1,805,338
2016876159,869$1,763,149
2017725162,253$2,076,294
2018871241,388$3,069,267
2019844224,202$2,624,703
2020646259,078$2,182,508
2021759282,993$2,637,922
2022818238,253$3,332,755
2023832202,261$3,078,315
20241,000253,481$4,253,018

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.6M2015 Drug cost: $945,186 (USD; Tot_Drug_Cst)2016 Drug cost: $719,773 (USD; Tot_Drug_Cst)2017 Drug cost: $990,597 (USD; Tot_Drug_Cst)2018 Drug cost: $1,557,040 (USD; Tot_Drug_Cst)2019 Drug cost: $1,597,577 (USD; Tot_Drug_Cst)2020 Drug cost: $2,300,240 (USD; Tot_Drug_Cst)2021 Drug cost: $2,511,705 (USD; Tot_Drug_Cst)2022 Drug cost: $2,087,173 (USD; Tot_Drug_Cst)2023 Drug cost: $2,218,008 (USD; Tot_Drug_Cst)2024 Drug cost: $4,619,072 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201581453$945,186
201685443$719,773
201786444$990,597
2018108568$1,557,040
2019105573$1,597,577
2020131692$2,300,240
2021126587$2,511,705
2022115562$2,087,173
2023114564$2,218,008
2024146764$4,619,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.8K$3.7K2015 Medicare payment: $3,009 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,679 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,462 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,506 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R32$3,009
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R50$3,679
2021N/R36$3,462
2022N/R41$1,506
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5891,085$72
82728Ferritin (blood protein) level309651$13
80053Blood test, comprehensive group of blood chemicals5291,789$10
83550Iron binding capacity309645$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5562,098$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide451,260$1,038,837
BrukinsaZanubrutinib601,800$856,282
JakafiRuxolitinib Phosphate381,140$546,735
RevlimidLenalidomide23644$444,246
BesremiRopeginterferon Alfa-2b-Njft22616$373,182

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$1,622Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Edward James Lee, M.D.?

Tedicare shows public-source Medicare data for Edward James Lee, M.D. (NPI 1043285190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward James Lee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward James Lee, M.D.?

Edward James Lee, M.D. is linked to MARYLAND ONCOLOGY HEMATOLOGY P.A. (billing NPI 1396710703) in the available physician profile data.

Does Edward James Lee, M.D. have Open Payments data?

Edward James Lee, M.D. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.